Currently, treatments are available and evolving for the “wet” form of AMD, most notably intravitreal injections of anti-vascular endothelial growth factor (VEGF) drugs, whereas there is as yet no effective cure for the “dry” form of AMD. This evidence concerns the gene VEGFA and age-related macular degeneration.